Article
Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite
8 Nov 2020
Abstract excerpt
Visceral Leishmaniasis (VL) is an insect-borne neglected disease caused by the protozoan parasite Leishmania donovani. In the absence of a commercial vaccine against VL, chemotherapy is currently the only option used for the treatment of VL. Vaccination has been considered as the most effective and powerful tool for complete eradication and control of infectious diseases. In this study, we aimed to design a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
